MLH1 and MSH2 expression in pterygia

被引:7
|
作者
Schneider, Barbara G.
Sahni, Deshdeepak
Torres, Juan C.
Dushku, Nicholas
Reid, Ted W.
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[3] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[4] Kaiser Permanente Med Ctr, Sacramento, CA USA
[5] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
关键词
pterygium; loss of heterozygosity; microsatellite instability; mismatch repair;
D O I
10.1097/ICO.0b013e3180316c76
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Pterygia have been reported to share some of the genetic defects seen in cancers, including microsatellite instability (MSI). We examined pterygia for the presence of proteins typically missing or defective in adenocarcinomas with MSI. We also performed microsatellite analysis on DNA from pterygia to test for instability in the size of the microsatellites, using markers conventionally used to characterize MSI in tumors (Bethesda convention markers). Methods: We examined 13 pterygia by immunohistochemistry for MLH1 and MSH2, 2 proteins involved in DNA mismatch repair. In addition, we amplified the pterygial DNA with primers specific for 5 Bethesda markers (BAT25, BAT26, D2S123, D5S346, and D17S250). Results: MLH1 staining was present at low levels in the basal cells of the cornea and migrating limbal cells of the pterygia. MSH2 staining was present in basal and in maturing epithelial cells of the cornea and migrating limbal cells of pterygia. We observed no reproducible examples of MSI or loss of heterozygosity (LOH). Conclusions: We were unable to confirm the presence of MSI and LOH by using the markers we examined. MSH2 staining appeared to be normal in pterygia. MLH1 staining was present but in reduced amounts compared with that seen in the conjunctiva.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 50 条
  • [1] MSH2 and MLH1 testing
    Grzegorz Kurzawski
    Janina Suchy
    Jan Lubiński
    [J]. Hereditary Cancer in Clinical Practice, 6
  • [2] MSH2 and MLH1 testing
    Kurzawski, Grzegorz
    Suchy, Janina
    Lubinski, Jan
    [J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2008, 6 (02) : 83 - 83
  • [3] Cloning of rat MLH1 and expression analysis of MSH2, MSH3, MSH6, and MLH1 during spermatogenesis
    Vani, RG
    Varghese, CM
    Rao, MRS
    [J]. GENOMICS, 1999, 62 (03) : 460 - 467
  • [4] Effects of MLH1 and MSH2 expression on imatinib resistance in CML
    Hekmatshoar, Y.
    Ozkan, T.
    Altinok, B.
    Karadag, A.
    Sunguroglu, A.
    [J]. FEBS JOURNAL, 2016, 283 : 162 - 162
  • [5] Expression of MLH1 and MSH2 in Urothelial Carcinoma of the Renal Pelvis
    Ehsani, L.
    Osunkoya, A. O.
    [J]. MODERN PATHOLOGY, 2013, 26 : 207A - 208A
  • [6] Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis
    Ehsani, Laleh
    Osunkoya, Adeboye O.
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 8743 - 8747
  • [7] Expression of MLH1 and MSH2 in Urothelial Carcinoma of the Renal Pelvis
    Ehsani, L.
    Osunkoya, A. O.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 207A - 208A
  • [8] MLH1 and MSH2 expression in 139 primary brain tumours
    Labrousse, F
    Paraf, F
    Petit, B
    Robert, S
    Delage-Corre, M
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 696 - 696
  • [9] MLH1 and MSH2 immunolabeling in carcinomas: High frequency of MLH1 loss of expression in endometrial carcinoma.
    Smith, KD
    Bronner, MP
    Haggin, RC
    Schmidt, RA
    [J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 85A - 85A
  • [10] Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine
    Planck, M
    Ericson, K
    Piotrowska, Z
    Halvarsson, B
    Rambech, E
    Nilbert, M
    [J]. CANCER, 2003, 97 (06) : 1551 - 1557